Literature DB >> 2286729

Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock.

B Stein1, E Pfenninger, A Grünert, J E Schmitz, M Hudde.   

Abstract

In order to assess the influence of continuous haemofiltration (HF) on haemodynamics and central blood volume in endotoxic shock, endotoxinaemia was invoked in 20 swine (28-32 kg). 15 min after doubling the mean pulmonary pressure, the animals were randomly assigned to receive either a zero-balanced veno-venous HF with an ultrafiltration and replacement rate of 600 ml/h (HF group, n = 10) or to observe the spontaneous course (E group, n = 10) under a constant infusion of endotoxin for 4 h. A trend to a higher survival rate in the HF group (6/10 vs. 3/10; E group) during the observation period was evident, but not statistically significant. Early initiation of HF during endotoxic shock modifies the haemodynamic response, lowering the pulmonary artery pressure (PAP), PCWP, pulmonary (PVR) and systemic vascular resistance (SVR), compared to the spontaneous course, whereas the decrement of central blood volume was comparable in both groups. These changes cannot be explained by effects of the HF on the volume status, but supports and additional effect by the filtration of small and medium-sized molecules.

Entities:  

Mesh:

Year:  1990        PMID: 2286729     DOI: 10.1007/bf01709399

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  20 in total

1.  [Control of the ultrafiltration rate as the main component of a new balancing system in continuous hemofiltration].

Authors:  B Stein; H Maucher; H Wiedeck; B Born; F W Ahnefeld
Journal:  Anaesthesist       Date:  1989-10       Impact factor: 1.041

2.  Hemodynamic changes during acetate dialysis, bicarbonate dialysis and hemofiltration.

Authors:  R Vagge; F Cavatorta; C Queirolo; P Rosselli; A Gentile; A Bertulla
Journal:  Blood Purif       Date:  1988       Impact factor: 2.614

3.  Thromboxane receptor-mediated bronchial and hemodynamic responses in ovine endotoxemia.

Authors:  P G Kühl; J M Bolds; J E Loyd; J R Snapper; G A FitzGerald
Journal:  Am J Physiol       Date:  1988-02

Review 4.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

Review 5.  Acute renal failure in the 1980s: the importance of septic shock and of endotoxaemia.

Authors:  N Wardle
Journal:  Nephron       Date:  1982       Impact factor: 2.847

6.  Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.

Authors:  L M McManus; D J Hanahan; C A Demopoulos; R N Pinckard
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

7.  Continuous high volume venous-venous haemofiltration in acute renal failure.

Authors:  J Wendon; M Smithies; M Sheppard; K Bullen; J Tinker; D Bihari
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 8.  Oxygen consumption in septic shock: collective review.

Authors:  B A Houtchens; D R Westenskow
Journal:  Circ Shock       Date:  1984

9.  A porcine model of early adult respiratory distress syndrome induced by endotoxaemia.

Authors:  T Borg; A Alvfors; B Gerdin; J Modig
Journal:  Acta Anaesthesiol Scand       Date:  1985-11       Impact factor: 2.105

Review 10.  Extracorporeal treatment of acute renal failure in the intensive care unit: a critical view.

Authors:  M Schetz; P M Lauwers; P Ferdinande
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

View more
  14 in total

1.  The haemodynamic effects of intermittent haemofiltration in critically ill patients.

Authors:  S J MacKenzie; G R Nimmo; I R Armstrong; I S Grant
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  The consequences of continuous haemofiltration on lung mechanics and extravascular lung water in a porcine endotoxic shock model.

Authors:  B Stein; E Pfenninger; A Grünert; J E Schmitz; A Deller; F Kocher
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

3.  Septic shock and multiple organ failure: treatment with haemofiltration?

Authors:  M Storck; W H Hartl; D Inthorn
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

4.  Septic shock and multiple organ failure: treatment with haemofiltration?

Authors:  A B Groeneveld
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

5.  On continuous haemofiltration.

Authors:  A Boba
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 6.  Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense?

Authors:  M Schetz; P Ferdinande; G Van den Berghe; C Verwaest; P Lauwers
Journal:  Intensive Care Med       Date:  1995-02       Impact factor: 17.440

7.  Haemodynamic effects of arteriovenous and venovenous haemofiltration in piglets.

Authors:  J H Reeves; W W Butt
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

8.  Effect of continuous hemofiltration on hemodynamics, lung inflammation and pulmonary edema in a canine model of acute lung injury.

Authors:  Xiao Su; Chunxue Bai; Qunying Hong; Duming Zhu; Lixian He; Jianping Wu; Feng Ding; Xiaohui Fang; Michael A Matthay
Journal:  Intensive Care Med       Date:  2003-10-14       Impact factor: 17.440

9.  Kinetics of plasmatic cytokines and cystatin C during and after hemodialysis in septic shock-related acute renal failure.

Authors:  Nicolas Mayeur; Lionel Rostaing; Marie B Nogier; Acil Jaafar; Olivier Cointault; Nassim Kamar; Jean M Conil; Olivier Fourcade; Laurence Lavayssiere
Journal:  Crit Care       Date:  2010-06-14       Impact factor: 9.097

10.  A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock.

Authors:  Nicolas Boussekey; Arnaud Chiche; Karine Faure; Patrick Devos; Benoit Guery; Thibaud d'Escrivan; Hugues Georges; Olivier Leroy
Journal:  Intensive Care Med       Date:  2008-04-30       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.